SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-070202
Filing Date
2023-12-14
Accepted
2023-12-14 07:30:02
Documents
6
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A itrm_def_proxy_pre-emp_n.htm DEF 14A 200324
2 GRAPHIC img93258025_0.jpg GRAPHIC 3845
3 GRAPHIC img93258025_1.jpg GRAPHIC 2403
4 GRAPHIC img93258025_2.jpg GRAPHIC 11646
5 GRAPHIC img93258025_3.jpg GRAPHIC 81222
6 GRAPHIC img93258025_4.jpg GRAPHIC 223269
  Complete submission text file 0000950170-23-070202.txt   626822
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38503 | Film No.: 231485558
SIC: 2834 Pharmaceutical Preparations